The Scientific Working Group is a strategic advisory group whose objective is to support the EBPMN association in multiple areas, such as the development of programs and projects in general, like webinars, definition and content creation with a global scope.
Dr. Ebrahim Mohamed, Biovac Institute, South Africa
Is a Synthetic Organic Chemist by training with 15 years’ experience in pharmaceuticals with expertise covering business development, product development, technology transfers, process optimizations, and cGMP.
After completing his Ph.D. from the University of Cape Town in 2009, he joined the Science and Innovation (S&I) Department at the Biovac Institute (BIOVAC) where he established his expertise in the development of glycoconjugate vaccines. As Group Leader he currently manages all the CMC related activities with the Science and Innovation department. He has accumulated experience in both inward and outward bound technology transfers of clinical vaccine candidates and commercial products. His responsibilities have expanded further to include support to manufacturing operations at Biovac.
In 2015 Ebrahim became a key member of the secretariat team of the African Vaccine Manufacturing Initiative (AVMI) where he has played a pivotal part in assisting with the coordination of the AVMI Vaccine Manufacturing and Procurement in Africa (VMPA) study. He was elected as a member of the board, representing the Southern African Region in 2016. Ebrahim has published several publications in reputable peer-reviewed journals.
Ms. Fabiana Belasco Guilhen Olivier, Instituto Butantan, Brazil
Ms. Olivier serves as Production Manager of Monoclonal Antibodies at Instituto Butantan. Olivier has been working at Butantan for over 22 years and has assumed responsibilities in several other areas related to vaccines production. She holds a degree in Chemistry from Mackenzie University and a Master's degree in Biotechnology from the Public University of São Paulo (USP).
Mrs. Yi O Cho, Instituto Butantan, Brazil
Mrs. Yi O Cho is the Regulatory Affairs manager of Instituto Butantan, since 2019. Mrs. Cho has more than 20 years of experience in regulatory field working for big pharma companies like Baxter, Novartis, Sanofi. She's responsible for all aspects of regulatory environment, for the new development products of Butantan's portfolio, vaccines and sera. This responsibility also includes management of the GMP requests, as well as export affairs affecting IB's products. Yi O Cho has a bachelor degree in Pharmacy and Biochemistry, post-graduation in Industrial administration, an MBA Project management and is currently seeking a master degree in Biotechnology and Bioprocesses.
Mr. Syed S Ahmed, TechInvention, India
In his current capacity as Director & CEO at TechInvention, Syed is leading quite a few strategic capacity building initiatives in LMIC's in the arena of Vaccines & Biologics. He is also steering R&D projects encompassing: Novel Biologics for infectious diseases as well as Vaccines with other 7 patents in its portfolio. These products are customizedto suit the needs of Developing countries. Also in its "Access" vertical at TechInvention, Syed has enabled Developing country vaccine manufacturers secure long term supply contracts as well established their products in MICs in a staged backward integration model successfully. Syed is a pharmacist with a post-graduation in Business Management with over 25 years of experience in leading strategic projects/initiatives in the pharmaceutical sector across Latam, Afric, Middle East & Asia.
Ms. Shaily Sethi, TechInvention, India
In her current capacity as Head Regulatory Affairs as TechInvention, Shaily is leading quite a few strategic regulatory in-licensing and out-licensing projects in the arena of Vaccines & Biologics and pharmaceuticals. Shaily is an accomplished pharma regulatory professional having 19 years of diverse work experience of creating patient and stakeholder value and expanding horizonts in healthcare in Indian (Reliance Life Sciences) and MNC Pharma organizations (GSK, Bayer and Abbott). Proven track record od successfully firming and executing novel regulatory strategies. Shaily is a pharmacist with a Master of Pharmacy in Pharmaceutical Sciences from BITS, Pilani.
Ms. Sushmita Mukherjee, TechInvention, India
Is heading the IP & Legal at TechInvention Lifecare Pvt Ltd. (TechInvention) and is responsible for the potential IP portfolio and strategic licensing in Biologics. She has more than 14 years of experience in Patent Portfolio management. She is MSc in Biochemistry and an LLB degree from Mumbai University, specialized in IP & Licensing> Prior to TechInvention, Sushmita has worked for several Indian Biopharma MNCs like Biocon Ltd, Glenmark Pharmaceutical, Aurobindo Pharma, and premier research institute National Chemical Laboratory, Pune (CSIR) and URDIP (CSIR).